MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, GRI made $11,998K in revenue. -$11,956K in net income. Net profit margin of -99.65%.

Income Overview

Revenue
$11,998K
Net Income
-$11,956K
Net Profit Margin
-99.65%
EPS
-$121.8
Unit: Thousand (K) dollars
Revenue Breakdown
    • Research and development
    • General and administrative
    • Interest income

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-12-31
Research and development
6,819
General and administrative
5,158
Total operating expenses
11,977
Loss from operations
-11,977
Change in fair value of warrant liability
0
Interest income
21
Net loss
-11,956
Deemed dividend on series b warrants
0
Net loss available to common stockholders
-11,956
Net loss per share of common stock, basic (in usd per share)
-121.8
Net loss per share of common stock, diluted (in usd per share)
-121.8
Weighted-average common shares outstanding, basic (in shares)
98,162
Weighted-average common shares outstanding, diluted (in shares)
98,162
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss availableto common...-$11,956K Net loss-$11,956K Interest income$21K Loss from operations-$11,977K Total operatingexpenses$11,977K General andadministrative$5,158K Research and development$6,819K

GRI Bio, Inc. (GRI)

GRI Bio, Inc. (GRI)